Stock Financial Ratios

PRXL / PAREXEL International Corp. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)4,597.78
Enterprise Value ($M)4,324.28
Book Value ($M)634.50
Book Value / Share12.16
Price / Book7.25
NCAV ($M)-398.50
NCAV / Share-16.87
Price / NCAV-11.54
Income Statement (mra) ($M)
Net Income107.30
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Quick Ratio1.45
Current Ratio1.54
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.14
Return on Assets (ROA)
Return on Equity (ROE)0.24
Identifiers and Descriptors
Central Index Key (CIK)799729
Industry Groups
SIC 8731 - Commercial Physical and Biological Research
Other Related CUSIPS
Share Statistics
Common Shares Outstanding51,115,310
Weighted Average Number Of Diluted Shares Outstanding52,200,000
Weighted Average Number Of Shares Outstanding Basic51,500,000
Common Stock Shares Outstanding51,100,000
Weighted Average Number Diluted Shares Outstanding Adjustment700,000
Preferred Stock Shares Outstanding0
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Current Per Share0.00
Liabilities Per Share26.87
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Cash Per Share0.00
Assets Per Share0.00
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share0.00
Liabilities Current Per Share0.00
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Debt Per Share9.66

Peers - Commercial Physical and Biological Research (8731)

Related News Stories

Marinus Pharmaceuticals: The Next Big Thing In CNS

2017-10-31 seekingalpha
Orphan drug designation, paired with unprecedented data, enables expedited approval of Ganaxolone in CDKL5 and additional orphan pediatric indications. (165-5)

IWM: Small Caps Caution Is The Word

2017-09-28 seekingalpha
A fundamental analysis indicates that many of the leading stocks comprising the IWM small caps ETF are trading at extremely high valuations coupled with relatively high short interest. (36-1)

PAREXEL's Acquisition by Pamplona Approved by Shareholders

2017-09-27 zacks
PAREXEL International Corporation (PRXL - Free Report) is again in the news following the receipt of shareholders’ approval for the impending sell-off of the company to certain investment funds associated with Pamplona Capital Management. The transaction is expected to be completed by Sep 29 following which the company will turn into a privately-held organization (15-1)

Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy

2017-09-20 zacks
Rep. Steve Scalise meant business when he had said, “We are not giving up on repealing and replacing Obamacare.”  Following a series of futile attempts by the GOP to dismantle the Affordable Care Act, the Republicans have pledged another solid shot at abolishing the program. (13-0)

BRIEF-Parexel's sharehodlers approve proposed acquisition by Pamplona Capital Management

2017-09-18 reuters
* Parexel International Corp - ‍78.3 percent of co’s shares outstanding were voted, with more than 98 percent of votes cast in favor of deal Source text for Eikon: Further company coverage: (1-0)

CUSIP: 699462107